{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:23:15Z","timestamp":1792790595065,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,4]]},"abstract":"<jats:p>Leukemia is a type of malignant tumor affecting hematopoietic system. Cervical cancer is a malignant tumor of female reproductive tract. The relationship between Calmodulin 3 (CALM3) and leukemia, cervical cancer remains unclear. Leukemia dataset GSE26294 and cervical cancer dataset GSE173097 profiles were downloaded from gene expression omnibus. Principal component analysis, differentially expressed genes (DEGs) screening, weighted gene co-expression network analysis (WGCNA), functional enrichment analysis, gene set enrichment analysis, immune infiltration analysis, protein\u2013protein interaction network construction and analysis, survival analysis were performed. Gene expression heatmaps were plotted. Comparative Toxicogenomics Database (CTD) was used to find diseases most related to core genes. 77 DEGs were identified. According to gene ontology, in biological process category, they were mainly enriched in cell proliferation, immune response, and apoptotic process. In cellular component category, they were mainly enriched in nucleus and Golgi apparatus. In molecular function category, they were mainly enriched in DNA binding, protein binding, transcription factor activity. In Kyoto encyclopedia of gene and genome analysis, they were mainly enriched in cell adhesion molecules, Wnt signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway, and basal cell carcinoma. The soft-threshold power in WGCNA was set to 1, generating 6 modules. Finally identifying 3 core genes (CALM3, secreted frizzled-related protein 4, plasminogen). CTD analysis revealed that core genes were related to leukemia, coagulation disorders, vaginal tumors, cervical tumors, autoimmune diseases, and inflammation. CALM3 is lowly expressed in leukemia samples and highly expressed in cervical cancer samples.<\/jats:p>","DOI":"10.1097\/md.0000000000041665","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:01:11Z","timestamp":1744804871000},"page":"e41665","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Screening and identification analysis of core markers for leukemia and cervical cancer: Calmodulin 3 as a core target"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0898-9703","authenticated-orcid":false,"given":"Danfeng","family":"Shao","sequence":"first","affiliation":[{"name":"Department of Gynaecology, Hangzhou Fuyang first people\u2019s Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiying","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, Hangzhou Fuyang first people\u2019s Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, The Second Affiliated Hospital of Medical College of Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250416","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000447076","article-title":"Leukemia.","volume":"43","author":"Juliusson","year":"2016","journal-title":"Prog Tumor Res"},{"key":"R2-20250416","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","article-title":"Leukaemia: a model metastatic disease.","volume":"21","author":"Whiteley","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"R3-20250416","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection.","volume":"2","author":"Schiffman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20250416","doi-asserted-by":"crossref","first-page":"e070115","DOI":"10.1136\/bmj-2022-070115","article-title":"Human papillomavirus vaccination and cervical cancer risk.","volume":"379","author":"Rahangdale","year":"2022","journal-title":"BMJ"},{"key":"R5-20250416","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.18632\/oncotarget.413","article-title":"AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications.","volume":"2","author":"Vakana","year":"2011","journal-title":"Oncotarget"},{"key":"R6-20250416","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mc.2940040302","article-title":"Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines.","volume":"4","author":"Wrede","year":"1991","journal-title":"Mol Carcinog"},{"key":"R7-20250416","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1002\/cpmb.68","article-title":"RNA-seq: basic bioinformatics analysis.","volume":"124","author":"Ji","year":"2018","journal-title":"Curr Protoc Mol Biol"},{"key":"R8-20250416","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fgene.2012.00287","article-title":"Bioinformatics of cancer ncRNA in high throughput sequencing: present state and challenges.","volume":"3","author":"Jorge","year":"2012","journal-title":"Front Genet"},{"key":"R9-20250416","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-018-0015-6","article-title":"A causal mechanism for childhood acute lymphoblastic leukaemia.","volume":"18","author":"Greaves","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"R10-20250416","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.3390\/cancers14194681","article-title":"Meta-analytic comparison of global RNA transcriptomes of acute and chronic myeloid leukemia cells reveals novel gene candidates governing myeloid malignancies.","volume":"14","author":"Jurgec","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R11-20250416","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12938-021-00973-6","article-title":"The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019.","volume":"21","author":"Yao","year":"2022","journal-title":"Biomed Eng Online"},{"key":"R12-20250416","doi-asserted-by":"crossref","first-page":"840616","DOI":"10.3389\/fonc.2022.840616","article-title":"Trends in disease burden of chronic lymphocytic leukemia at the global, regional, and national levels from 1990 to 2019, and projections until 2030: a population-based epidemiologic study.","volume":"12","author":"Ou","year":"2022","journal-title":"Front Oncol"},{"key":"R13-20250416","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/ajh.25214","article-title":"Acute myeloid leukemia: 2019 update on risk-stratification and management.","volume":"93","author":"Estey","year":"2018","journal-title":"Am J Hematol"},{"key":"R14-20250416","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1186\/s12889-023-16226-1","article-title":"Epidemiological characteristics of leukemia in China, 2005-2017: a log-linear regression and age-period-cohort analysis.","volume":"23","author":"Lin","year":"2023","journal-title":"BMC Public Health"},{"key":"R15-20250416","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13045-020-00908-z","article-title":"The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017.","volume":"13","author":"Yi","year":"2020","journal-title":"J Hematol Oncol"},{"key":"R16-20250416","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"R17-20250416","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"R18-20250416","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2007\/914823","article-title":"The epidemiology of human papillomavirus infection and cervical cancer.","volume":"23","author":"Bosch","year":"2007","journal-title":"Dis Markers"},{"key":"R19-20250416","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12885-017-3124-9","article-title":"Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16.","volume":"17","author":"Hong","year":"2017","journal-title":"BMC Cancer"},{"key":"R20-20250416","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3390\/ijms19061706","article-title":"High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis.","volume":"19","author":"Yeo-Teh","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R21-20250416","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"R22-20250416","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12905-023-02264-9","article-title":"Barriers to early diagnosis of cervical cancer: a mixed-method study in C\u00f4te d\u2019Ivoire, West Africa.","volume":"23","author":"Plaisy","year":"2023","journal-title":"BMC Womens Health"},{"key":"R23-20250416","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/diagnostics13040610","article-title":"Prevention strategies and early diagnosis of cervical cancer: current state and prospects.","volume":"13","author":"Kakotkin","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R24-20250416","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13643-020-01538-9","article-title":"Screening for the prevention and early detection of cervical cancer: protocol for systematic reviews to inform Canadian recommendations.","volume":"10","author":"Gates","year":"2021","journal-title":"Syst Rev"},{"key":"R25-20250416","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1186\/s12885-021-08361-y","article-title":"Coordinated action of human papillomavirus type 16 E6 and E7 oncoproteins on competitive endogenous RNA (ceRNA) network members in primary human keratinocytes.","volume":"21","author":"L\u00e1szl\u00f3","year":"2021","journal-title":"BMC Cancer"},{"issue":"suppl 1","key":"R26-20250416","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2091-9-S1-S4","article-title":"HPV E6, E6AP and cervical cancer.","volume":"9","author":"Beaudenon","year":"2008","journal-title":"BMC Biochem"},{"key":"R27-20250416","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.3389\/fmicb.2019.03116","article-title":"Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy.","volume":"10","author":"Pal","year":"2019","journal-title":"Front Microbiol"},{"key":"R28-20250416","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/cancers8100095","article-title":"Functional roles of E6 and E7 oncoproteins in HPV-induced malignancies at diverse anatomical sites.","volume":"8","author":"Tomai\u0107","year":"2016","journal-title":"Cancers (Basel)"},{"key":"R29-20250416","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/biom8030057","article-title":"Calmodulin: a multitasking protein in Kv7.2 potassium channel functions.","volume":"8","author":"Alaimo","year":"2018","journal-title":"Biomolecules"},{"key":"R30-20250416","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1432-1033.2003.03414.x","article-title":"Novel aspects of calmodulin target recognition and activation.","volume":"270","author":"Vetter","year":"2003","journal-title":"Eur J Biochem"},{"key":"R31-20250416","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.physiol.70.113006.100455","article-title":"Calcium cycling and signaling in cardiac myocytes.","volume":"70","author":"Bers","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"R32-20250416","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13041-015-0166-2","article-title":"Calcium\/calmodulin-dependent kinase II and Alzheimer\u2019s disease.","volume":"8","author":"Ghosh","year":"2015","journal-title":"Mol Brain"},{"key":"R33-20250416","doi-asserted-by":"crossref","first-page":"e36027","DOI":"10.1097\/MD.0000000000036027","article-title":"CALM3 affects the prognosis of leukemia and hemorrhoids.","volume":"102","author":"He","year":"2023","journal-title":"Medicine (Baltimore)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:01:16Z","timestamp":1744804876000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":33,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041665","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]}}}